Skip to main content
Log in

Serum IGF-1 levels are associated with sarcopenia in elderly men but not in elderly women

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Sarcopenia is an age-associated decline in muscle mass that negatively affects the metabolic rate, strength, and function of the body and ultimately leads to a decrease in quality of life. Insulin-like growth factor 1 (IGF-1) is a modulator of muscle mass and muscle function. There is evidence that IGF-1 is related to the appendicular skeletal muscle mass index (ASMI) and grip strength. The aim of this study was to explore the relationship between serum IGF-1 levels and sarcopenia in older people.

Methods

In this cross-sectional survey of 984 people older than 60 years old, we used the 2019 criteria of the Asian Working Group for Sarcopenia (AWGS) to define sarcopenia. We collected demographic variables, measured ASMI and grip strength, and detected serum IGF-1 data. The levels of serum IGF-1 were separated into quintiles (Q1–Q5).

Results

Adjusted for age, education level, smoking, number of diseases and BMI, the multivariable linear regression analysis revealed that serum IGF-1 levels were related to ASMI in elderly men (coefficient = 0.03, 95% CI = 0.02–0.05, P < 0.001) but were not related to their grip strength. There was no significant relationship between serum IGF-1 levels and ASMI or grip strength in elderly women. The multivariable log-binomial regression analysis showed that higher serum IGF-1 levels were associated with a lower prevalence of sarcopenia in elderly men (prevalence ratio (PR) = 0.99, 95% CI = 0.98–1.00, P < 0.05) but not in elderly women.

Conclusion

Serum IGF-1 levels were highly correlated with sarcopenia in older men. Further studies are needed to further explore the possible reasons for the observed difference between genders. Serum IGF-1 might predict sarcopenia prevalence in elderly men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. The Seventh National Census Bulletin (No. 1)-Basic Information on the Work of the Seventh National Census. National Bureau of Statistics, Office of the Leading Group for the Seventh National Census of the State Council. http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818820.html. Accessed on 11 May 2021

  2. Fang EF, Scheibye-Knudsen M, Jahn HJ et al (2015) A research agenda for aging in China in the 21st century. Ageing Res Rev 24:197–205. https://doi.org/10.1016/j.arr.2015.08.003

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mitchell WK, Williams J, Atherton P et al (2012) Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 3:260. https://doi.org/10.3389/fphys.2012.00260

    Article  PubMed  PubMed Central  Google Scholar 

  4. Barbieri M, Ferrucci L, Ragno E et al (2003) Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 284:E481–E487. https://doi.org/10.1152/ajpendo.00319.2002

    Article  CAS  PubMed  Google Scholar 

  5. Jiang Q, Lou K, Hou L et al (2020) The effect of resistance training on serum insulin-like growth factor 1(IGF-1): a systematic review and meta-analysis. Complement Ther Med 50:102360. https://doi.org/10.1016/j.ctim.2020.102360

    Article  PubMed  Google Scholar 

  6. Caputo M, Pigni S, Agosti E et al (2021) Regulation of GH and GH signaling by nutrients. Cells 10:1376. https://doi.org/10.3390/cells10061376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Volpato S, Bianchi L, Cherubini A et al (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 69:438–446. https://doi.org/10.1093/gerona/glt149

    Article  CAS  PubMed  Google Scholar 

  8. Yang C-W, Li T-C, Li C-I et al (2015) Insulinlike growth factor-1 and Its binding protein-3 polymorphisms predict circulating IGF-1 level and appendicular skeletal muscle mass in Chinese elderly. J Am Med Dir Assoc 16:365–370. https://doi.org/10.1016/j.jamda.2014.11.015

    Article  PubMed  Google Scholar 

  9. Hassan-Smith ZK, Morgan SA, Sherlock M et al (2015) Gender-specific differences in skeletal muscle 11β-HSD1 expression across healthy aging. J Clin Endocrinol Metab 100:2673–2681. https://doi.org/10.1210/jc.2015-1516

    Article  CAS  PubMed  Google Scholar 

  10. Fulle S, Belia S, Di Tano G (2005) Sarcopenia is more than a muscular deficit. Arch Ital Biol 143:229–234. https://doi.org/10.4449/aib.v143i3.328

    Article  CAS  PubMed  Google Scholar 

  11. Chen L-K, Woo J, Assantachai P et al (2020) Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21:300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012

    Article  PubMed  Google Scholar 

  12. Musarò A, Scicchitano BM (2019) Counteracting sarcopenia: the role of IGF-1 isoforms. Aging (Albany NY) 11:3410–3411. https://doi.org/10.18632/aging.102027

    Article  Google Scholar 

  13. Ishii S, Tanaka T, Shibasaki K et al (2014) Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 14:93–101. https://doi.org/10.1111/ggi.12197

    Article  PubMed  Google Scholar 

  14. Bian A, Ma Y, Zhou X et al (2020) Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord 21:214. https://doi.org/10.1186/s12891-020-03236-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gielen E, O’Neill TW, Pye SR et al (2015) Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J Cachexia Sarcopenia Muscle 6:242–252. https://doi.org/10.1002/jcsm.12030

    Article  PubMed  PubMed Central  Google Scholar 

  16. Moriwaki K, Matsumoto H, Tanishima S et al (2019) Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study. BMC Musculoskelet Disord 20:276. https://doi.org/10.1186/s12891-019-2650-9

    Article  PubMed  PubMed Central  Google Scholar 

  17. Chen L-Y, Yi-Hui Wu, Liu L-K et al (2018) Association among serum insulin-like growth factor-1, frailty, muscle mass, bone mineral density, and physical performance among community-dwelling middle-aged and older adults in Taiwan. Rejuvenation Res 21:270–277. https://doi.org/10.1089/rej.2016.1882

    Article  CAS  PubMed  Google Scholar 

  18. van Nieuwpoort IC, Vlot MC, Schaap LA et al (2018) The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women. Eur J Endocrinol 179:73–84. https://doi.org/10.1530/EJE-18-0076

    Article  PubMed  Google Scholar 

  19. Higashi Y, Sukhanov S, Shai SY et al (2016) Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice. Circulation 133:2263–2278. https://doi.org/10.1161/CIRCULATIONAHA.116.021805

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hägg S, Jylhävä J (2021) Sex differences in biological aging with a focus on human studies. Elife 13:e63425. https://doi.org/10.7554/eLife.63425

    Article  Google Scholar 

  21. Shang Y, Kuang M, Wang Z et al (2020) An ultrashort peptide-based supramolecular hydrogel mimicking IGF-1 to alleviate glucocorticoid-induced sarcopenia. ACS Appl Mater Interfaces 12:34678–34688. https://doi.org/10.1021/acsami.0c09973

    Article  CAS  PubMed  Google Scholar 

  22. Nakashima K, Ishida A, Shimamoto S et al (2017) Effects of insulin-like growth factor-I on the expression of atrogin-1/MAFbx in chick myotube cultures. J Poult Sci 54:247–252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Schakman SK, Bertrand L, Lause P et al (2008) Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats. Endocrinology 149:3900–3908

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was funded by the National Key Research and Development Program of China (2018YFC2000301), the National Natural Science Foundation of China (81701366), the "Pioneer" and "Leading Goose" R&D Program of Zhejiang (2022C03161), the Medical Health Science and Technology Project of Zhejiang Province (2020KY549).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qin Zhang.

Ethics declarations

Conflict of interest

None.

Ethical approval

Ethics for this research was obtained from Ethics Review Committee of the First. Affiliated Hospital of Zhejiang University School of Medicine.

Informed consent

All participants signed written informed consent forms.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, Jj., Chen, Sm., Chen, J. et al. Serum IGF-1 levels are associated with sarcopenia in elderly men but not in elderly women. Aging Clin Exp Res 34, 2465–2471 (2022). https://doi.org/10.1007/s40520-022-02180-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-022-02180-2

Keywords

Navigation